COCOZZA NANCY G 4

What Happened

• Nancy G. Cocozza, a director of Privia Health Group, Inc. (PRVA), was granted 8,463 restricted stock units (RSUs) on May 20, 2026. The grant is reported at $0 purchase price (typical for stock awards) and represents a compensation award rather than a market purchase or sale.
• The RSUs will vest on the earlier of (i) the day immediately preceding the company’s 2027 annual meeting of stockholders or (ii) the first anniversary of the grant date.

Key Details

• Transaction date: May 20, 2026; Transaction type/code: Award (A); Reported acquisition price: $0.00.
• Shares/units granted: 8,463 RSUs.
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Vesting footnote: RSUs vest on the earlier of the day before the 2027 annual meeting or the one-year anniversary of the grant.
• Filing: Form 4 filed May 22, 2026 (covers transaction dated May 20, 2026) — appears timely under the two-business-day reporting rule.

Context

• RSU grants are a form of compensation and do not represent an immediate cash purchase or sale; vested RSUs convert to shares (often subject to tax withholding) only when they vest.
• This is a routine director compensation award and should not be read as an immediate bullish or bearish trade signal.